Use of neuroglobin agonist for preventing or treating mitochondrial RCCI and/or RCCIII deficiency disease

• 收藏
• 分享

专利权人:

Sanofi;Universite Pierre et Marie Curie (Paris 6);Centre National De La Recherche Scientifique (C.N.R.S.);Institut National De La Sante Et De La Recherche Medicale (Inserm)

发明人:

Marisol Corral-Debrinski,Christophe Lechauve,José-Alain Sahel,Thomas Debeir

申请号：

US14502768

公开号：

US20150094360A1

申请日:

2014.09.30

申请国别(地区):

US

年份:

2015

代理人:

摘要：

The present invention concerns a neuroglobin agonist for use in the treatment or prevention of a mitochondrial disease associated with respiratory chain complex I (RCCI) deficiency and/or respiratory chain complex III (RCCIII) deficiency.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/